- A. Health Biotechnology
- Areas of activity
- In vitro diagnostics
- Drug development
- Drug discovery
- Therapeutic areas
- Cardiovascular diseases and circulatory system
- Digestive system and hepatology
- Central nervous system
- Metabolic disorders / Endocrinology
- B. Agrifood Biotechnology
- Agriculture / veterinary / environmental
- Animal health / Veterinary
- Animal Food / Feed
- Functional Food
- Vitamins and nutrition products
- D. Services
- R&D services
OWL is a biotechnology company with the mission to identify biomarkers and therapeutic targets in the field of high prevalence diseases. Its technological platform offers metabolomics and lipidomics services to Pharma, Biotech companies ,Research Centers and Food and Cosmetic companies.
OWL is focused in the area of health, with pioneering scientific applications, and its goal is to identify, validate, patent and commercialize diagnosis and/or prognosis systems, as well as therapeutic targets.
OWL is a biotechnology company in the field of Metabolomics with pioneering diagnostics products and unique R&D services for the scientific community.
Metabolomics uncovers metabolic alterations in biological samples and provides an overall picture of human or animal health: The information on complex biochemical processes obtained is highly valuable in drug mechanism and toxicology studies, biomarker discovery and the optimization of biotechnological processes.
OWL´s two business lines stem from our in depth knowledge of metabolomics and liver diseases:
OWLiver Test is the first in vitro test for determining steatosis and NASH. The company also develops diagnostic markers research for high prevalence diseases.
OWL applies its expertise in metabolomics and lipidomics to provide services to the pharmaceutical, food and cosmetics industries, as well as research centers, biotech companies and CROs.